Results 21 to 30 of about 2,115 (174)
ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors
ABSTRACT The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence‐based statements on the preoperative ...
D. Timmerman +20 more
wiley +1 more source
Gynaecological cancer patients in Europe appeal for more transparency and continuation of high standard oncologic care even in times of crisis like the COVID‐19 pandemic. Abstract Background The impact of the COVID‐19 pandemic on European gynaecological cancer patients under active treatment or follow‐up has not been documented.
Murat Gultekin +35 more
wiley +1 more source
Abstract Objectives To develop and test the performance of computerized ultrasound image analysis using deep neural networks (DNNs) in discriminating between benign and malignant ovarian tumors and to compare its diagnostic accuracy with that of subjective assessment (SA) by an ultrasound expert.
F. Christiansen +5 more
wiley +1 more source
Polycystic ovary syndrome (PCOS) is a frequent gynecological female endocrinopathy, characterized by chronic anovulation, hyperandrogenism, and insulin resistance (IR). Menstrual disorders are one of the main clinical manifestations of PCOS. Other symptoms include hirsutism and/acne.
Yuehui Zhang +10 more
wiley +1 more source
Introducción: La supervivencia del cáncer de ovario se aproxima al 50%, sin embargo, varía en función de los distintos factores pronósticos, siendo el principal la extensión de la enfermedad al diagnóstico. El objetivo del presente estudio fue establecer
Rommel Espinoza De Los Monteros +2 more
core +1 more source
FRECUENCIA DE POSITIVIDAD DE MARCADORES TUMORALES CA-125 Y CEA EN PACIENTES CON CÁNCER DE OVARIO DEL HOSPITAL DE ESPECIALIDADES MÉDICAS JOSÉ CARRASCO ARTEAGA PERIODO 2019 [PDF]
El cáncer epitelial de ovario representa la quinta causa de mortalidad con una incidencia de 6-14 casos por 100.000 en Europa. El 90% de tumores de ovario se origina en las células epiteliales siendo las mujeres postmenopáusicas las más susceptibles a ...
Mora Aguilar, Jorely Maricela +1 more
core
Cancer stands out among the causes of death after heart disease. In the female population, ovarian cancer becomes more lethal than breast cancer, less than half of the women affected by the disease, live more than five years after the initial diagnosis ...
Paizano Vanega, Gindreska +1 more
core +2 more sources
Índice de irresecabilidad asociado a citorreducción óptima en pacientes con cáncer de ovario
Introducción: El índice de irresecabilidad valora la presencia de cuatro variables (masa abdominal palpable, tumor en fondo de saco de Douglas, presencia de líquido ascítico, valor preoperatorio de Ca 125 mayor a 1000 U/ml); previo a la realización de ...
Maria Lucila Carrasco Guerra +1 more
core +1 more source
Nuevas aproximaciones para el tratamiento del cáncer de ovario [PDF]
[ES] El cáncer de ovario es el tipo de cáncer ginecológico con peores ratios de supervivencia debido, principalmente, a un diagnóstico en estadios avanzados de la enfermedad y a la aparición de resistencias y recaídas al tratamiento quimioterápico ...
Ovejero-Sánchez, María
core +1 more source
Serous ovarian cancer is now understood to arise in the fallopian tubes. Prophylactic salpingectomy to reduce the risk of ovarian cancer is widely recommended at gynaecological surgery in appropriate women. This article explores prophylactic salpingectomy at the time of non‐gynaecological surgery.
G. Tomasch +14 more
wiley +1 more source

